Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type

https://doi.org/10.1016/S0925-4927(99)00004-9Get rights and content

Abstract

In longitudinal brain studies of dementia of the Alzheimer type (DAT), the cerebellum is often used as a reference region for single photon emission computed tomography (SPECT) quantification, which assumes no significant regional influence of physiological fluctuations or pathology. With the use of absolute quantification in DAT patients, reproducibility of cerebellar uptake of technetium-99m-d,l-hexamethylpropyleneamine oxime (HMPAO) was tested and compared with the mean absolute cerebellar tracer uptake value in DAT patients and healthy control subjects. In 13 DAT patients SPECT studies were repeated within 2 weeks to assess reproducibility of cerebellar regional brain uptake (rBU). With calibrated point sources as scaling factors, cerebellar activity was expressed as rBU of HMPAO per cm3 brain tissue in percent of the injected lipophilic dose of 740 MBq (20 mCi). Also, mean cerebellar rBU in patients suffering from DAT was calculated and compared with a previously established database obtained in healthy volunteers. Repeated SPECT studies within a 2-week interval in clinically stable patients resulted in a mean rBU increase of 6.8±10.3% in the second SPECT study as compared with the first. A similar shift was previously reported in healthy volunteers. Mean cortical cerebellar rBU values in DAT patients and in the healthy reference population concurred, after cumulative corrections for body surface and for a mean brain volume of 1350 ml (obtained in healthy control subjects), showing respective mean values of 53.9±7.4 and of 52.0±7.3×10−6 of the injected lipophilic dose 740 MBq (20 mCi) of HMPAO per cm3 of brain tissue. A unidirectional shift in mean absolute cerebellar uptake values occurs between repeat SPECT examinations in DAT patients similar to previous findings in a group of healthy volunteers. The origin of this phenomenon remains elusive but deserves further study with regard to SPECT (semi)quantification in DAT patients. Most interestingly, the presented findings suggest that with the use of HMPAO SPECT in DAT patients the cerebellum remains scintigraphically uninvolved.

Introduction

The authors previously validated a simple quantification method to convert single photon emission computed tomography (SPECT) brain counts into absolute values of regional brain uptake (rBU) of technetium-99m-d,l-hexamethylpropyleneamine oxime (HMPAO), using calibrated point sources as an external standard (Dobbeleir and Dierckx, 1993). Reproducibility studies of cerebellar uptake in a group of 15 subjects, comprising 10 healthy volunteers and five patients, showed a mean deviation of 12.6%. On the other hand, expected large interindividual variability was noted, with cerebellar uptake varying between 31.9 and 72.2×10−6 of the injected lipophilic dose of 740 MBq (20 mCi) of HMPAO per cm3 of brain tissue (Dobbeleir and Dierckx, 1993). A study assessing parameters influencing rBU in 33 healthy volunteers demonstrated that the most important factor underlying interindividual variability was body surface, followed by brain volume. In addition, the previous study stressed the need for registration of basal (`rest') heart rate and also suggested the absence of a significant influence of minor stress on rBU (Dierckx et al., 1994).

As demonstrated by neuropathologial validation, perfusion SPECT has been confirmed to increase the accuracy of diagnoses of Alzheimer's disease (Jobst et al., 1992, Jobst et al., 1997). Although already qualitatively useful as shown by Jobst et al., regional quantitative analysis with a reference region is expected to offer more accurate information. In this context, for longitudinal studies in patients with dementia of the Alzheimer type (DAT), the cerebellum is presently often used as a reference region for SPECT semi-quantification, which assumes the absence of any significant regional influence of physiological fluctuations or pathology (Syed et al., 1992). The rBU quantification method allows testing of the validity of these assumptions by direct assessment of the methodology, i.e. the regional brain uptake of the tracer Tc-99m HMPAO rather than extrapolated regional cerebral blood flow.

Hence, in 13 DAT patients, repeated SPECT studies were performed to assess the reproducibility of cerebellar rBU. Also, mean cerebellar rBU in patients suffering from DAT was calculated, respectively, at resting heart rate, after correction for body surface and after cumulative corrections for body surface and brain volume. This allowed determination of the mean cerebellar rBU for the whole DAT group and comparison with a previously established database obtained in healthy volunteers. It should be stressed that the aim of the SPECT analysis in the DAT patients presented was to address methodological questions, rather than to explore correlations between functional and clinical parameters.

Section snippets

Subjects

Thirteen DAT patients underwent repeated SPECT studies separated by an interval of approximately 2 weeks. It is well known that DAT patients show decreased habituation to novel situations. An effort was made to control variance by keeping the patients in as stable as possible life conditions between scans. Patients were either hospitalized (n=7) or living at home (n=6) during both acquisitions. Inclusion criteria for DAT patients consisted of the diagnosis of probable DAT, according to

Results

As the first clinical population in which to test the rBU quantification method, a group of 13 patients suffering from probable DAT was examined. In addition to the validation of the proposed absolute quantification method in a clinical setting, the results obtained allowed evaluation of the aforementioned hypotheses using perfusion SPECT in patients suffering from DAT. Since only cerebellar and no global cerebral regional analyses were performed, a heterogeneous series of patients with

Discussion

In the study presented, the implementation in clinical neurology and psychiatry of the absolute Tc-99m HMPAO uptake quantification method, using calibrated point sources as an external standard, was explored. The reproducibility and methodological simplicity of the rBU quantification was previously validated on phantoms and in a reference population (Dobbeleir and Dierckx, 1993; Dierckx et al., 1994).

Repeated studies of cerebellar rBU in 13 patients suffering from DAT showed a mean deviation of

Acknowledgements

The authors are grateful to Dr J. Vandevivere for logistical support, and to Mrs D. Welvaert and Ms S. Van den Broeck for secretarial assistance.

References (20)

  • V.D. Deshmukh et al.

    Stress-adaptation failure hypothesis of Alzheimer's disease

    Medical Hypotheses

    (1990)
  • M.F. Folstein et al.

    `Mini-Mental-State': a practical method for grading the cognitive state of patients for the clinician

    Journal of Psychiatric Research

    (1975)
  • I. Prohovnik et al.

    Observations on the functional significance of regional cerebral blood flow in `resting' normal subjects

    Neuropsychologia

    (1980)
  • J. Balldin et al.

    Relationship between mental impairment and HPA axis activity in dementia disorders

    Dementia

    (1994)
  • R.A. Dierckx et al.

    Parameters influencing SPECT regional brain uptake of Tc-99m HMPAO measured by calibrated point sources as an external standard

    European Journal of Nuclear Medicine

    (1994)
  • A. Dobbeleir et al.

    Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies

    European Journal of Nuclear Medicine

    (1993)
  • K.P. Ebmeier et al.

    The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker exametazime and single photon emission computerized tomography (SPECT): reproducibility and rater reliability

    International Journal of Methods in Psychiatric Research

    (1991)
  • C.G. Gottfries et al.

    Regulation of the hypothalamic–pituitary–adrenal axis in dementia disorders

    Annals of the New York Academy of Sciences

    (1994)
  • K.A. Jobst et al.

    Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and apo E4 in medial temporal lobe dementias

    International Psychogeriatrics

    (1997)
  • K.A. Jobst et al.

    Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease

    Journal of Neurology, Neurosurgery and Psychiatry

    (1992)
There are more references available in the full text version of this article.

Cited by (38)

  • Efficacy of nicergoline treatment in Parkinson's disease associated with dementia

    2019, Journal of Clinical Neuroscience
    Citation Excerpt :

    Then, images were spatially normalized to the SPM SPECT template (Montreal Neurological Institute, McGill University, Montreal, Canada). After spatial normalization, images were re-sliced with a voxel size of 2.0 × 2.0 × 2.0 mm and scaled to the mean intensity of the cerebellum [10,11] using the MarsBar toolbox [12] and Automated Anatomical Labeling atlas.[13] All images were smoothed with a 16 mm full-width half-maximum Gaussian kernel.

  • Generation of realistic HMPAO SPECT images using a subresolution sandwich phantom

    2013, NeuroImage
    Citation Excerpt :

    16 mm is in routine clinical use for dementia imaging in the centres involved in this study (Kemp et al., 2003, 2005) and 16–18 mm was found to be optimal in a previous study using a subresolution phantom (Van Laere et al., 2002a). The confounding effect of global activity was removed via automated count re-scaling to the cerebellum, a structure known to be relatively uninvolved in dementia (Pickut et al., 1999; Soonawala et al., 2002). Further processing (creation of the mean database image used in the next section, calculation of the difference measure etc.) was performed on normalised, smoothed and scaled images.

  • 5-<sup>123</sup>I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment

    2010, Neurobiology of Aging
    Citation Excerpt :

    It is sufficiently large to be less liable to partial volume effects experienced by smaller regions. It is also considered to be without major pathological involvement in Alzheimer's disease (Elser et al., 1996; Pickut et al., 1999; Soonawala et al., 2002); (2) the corpus callosum (CC), which has previously been said to exhibit only non-specific uptake (Staley et al., 2005); (3) SPM2's default: global mean activity within the boundaries of 90% maximum activity. The cerebellar binary mask was created and used as described previously (Soonawala et al., 2002), the corpus callosum mask by using the segmentation tool in Analyze and the single subject T1 weighted MRI supplied with SPM.

  • Tumor Necrosis Factor as a Neuroinflammatory Mediator in Alzheimer's Disease and Stroke: Molecular Mechanisms and Neuroinflammatory Imaging

    2010, NeuroImmune Biology
    Citation Excerpt :

    A previous study had already concluded that the cerebellum is the more appropriate choice of reference region in the quantification of perfusion singlephoton emission computed tomography (SPECT) in primary degenerative dementia [84]. With regard to perfusion SPECT imaging, the cerebellum was shown to be scinti-graphically uninvolved [85]. PK11195 (1-[2-chlorophenyl]-N-[1-methyl-propyl]-3-iso-quinoline carboxamide) is a specific and selective high-affinity ligand for the peripheral benzodiazepine receptor (PBR), and in this way can be used as a marker for neuroinflammatory lesions [86–88].

View all citing articles on Scopus
View full text